Iskalni niz:
išči po
išči po
išči po
išči po
Vrsta gradiva:
Jezik:
Št. zadetkov: 1
Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab
Peter Popović, Ana Kalamutova, Mihajlo Djokić, Anka Cuderman, Gasper Boltezar, Blaz Trotovsek
Izvirni znanstveni članek
Oznake:
Background: The current Barcelona Clinic Liver Cancer (BCLC) classification recommends systemic treatment with atezolizumab and bevacizumab as the first-line therapy for advanced hepatocellular carcinoma (HCC). Recent studies suggest that combining systemic immunotherapy with locoregional treatments ...
Leto: 0 Vir: Digitalni repozitorij raziskovalnih organizacij Slovenije
Št. zadetkov: 1
Leto izdaje:
Avtorji:
Repozitorij:
Tipologija:
Jezik: